비만/항암제 메가트렌드 지속｜2026 한국 바이오 지금 어디쯤? /신한투자증권 엄민용

#ProductiveFinance #PharmaceuticalsBio #NationalGrowthFund #MegaProject [Shinhan Premier Research] Blue Book; Productive Finance II Pharmaceuticals & Bio: Team Leader Minyong Um, Research Division 00:00 Opening 00:28 Domestic and International Pharmaceutical & Bio Industry Value Chains 01:49 Global Trend: Continued Dominance by Obesity/Anticancer Drugs 10:00 Domestic Trend: Upward Trend in New Drug Capabilities 12:30 Domestic Industry Competitiveness in the Global Market 13:50 Areas of Competitive Disadvantage and Strategies to Overcome Them 15:07 The Role of Productive Finance in the Industry 18:26 Conclusion ▶ [Blue Book; [Productive Finance II] Material Download Link ☞ https://bbs2.shinhansec.com/board/mes... (If the link does not open immediately, please press Ctrl+J for web downloads / check your mobile download folder!) ▶ Investor Notice ※ This video was produced based on the research and analysis materials from the Shinhan Investment & Securities Research Center. This material is based on the content of [Blue Book; Productive Finance II] (April 6, 2026). The relevant research and analysis materials are available for viewing on our website (www.shinhansec.com). ※ This video is intended to provide information that serves as a reference for investors' investment decisions, not to induce investment. Therefore, please make your own judgment regarding stock selection or final investment decisions. ※ This video complies with Shinhan Investment & Securities' internal control standards regarding the external provision of investment information, etc. Copyright Ⓒ Alpha TV – Shinhan Investment & Securities [Official YouTube Channel]. All rights reserved. Unauthorized reproduction, redistribution, and use for AI learning are prohibited.